Pliant Therapeutics Inc (PLRX)
NASDAQ
Fin d'année 31 Décembre 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -105.674 | -7.388 | -20.036 | -37.645 | -43.132 | -37.4 |
Return on Equity (%) | 98.37 | 9.28 | -40.174 | -40.348 | -48.135 | -41.005 |
Return on Invested Capital (%) | -102.882 | -1.474 | -21.384 | -40.569 | -48.82 | -45.771 |
Operating Margin (%) | N/A | -1.106 | -99.321 | -1284.509 | -1265.152 | -10130.949 |
Net Profit Margin (%) | N/A | -12.017 | -99.321 | -1284.509 | -1273.32 | -10211.139 |
Book Value Per Share | 6.222 | 8.332 | 7.962 | 5.517 | 6.402 | 7.907 |
Earnings Per Share | -3.607 | -0.519 | -1.168 | -2.696 | -2.52 | -2.694 |
Cash Per Share | 6.254 | 6.501 | 1.431 | 1.432 | 0.688 | 1.056 |
Working Capital Per Share | 5.813 | 7.859 | 7.852 | 5.338 | 6.465 | 7.963 |
Operating Profit Per Share | N/A | 4.322 | 1.176 | 0.21 | 0.198 | 0.026 |
EBIT Per Share | -3.107 | -0.048 | -1.168 | -2.696 | -2.52 | -2.694 |
EBITDA Per Share | -3.107 | -0.048 | -1.168 | -2.696 | -2.52 | -2.694 |
Free Cash Flow Per Share | -3.437 | -0.531 | -1.162 | -2.684 | -2.521 | -2.709 |
Fin d'année 31 Décembre 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 9,75M | 13,2M | 35,55M | 36,08M | 48,94M | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |||
Actions en circulation | 48,94M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | -2795.571 | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | -2818.919 | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 691,91M |
Ratio cours/bénéfice | -4,29 |
Ratio prix/ventes | 437,31 |
Ratio prix/liquidités | 10,94 |
Ratio prix/valeur comptable | 1,46 |
Rendement de dividende | - |
Actions en circulation | 60,85M |
Volume moyen (1 semaine) | 473,85k |
Volume moyen (1 mois) | 489,65k |
Variation sur 52 semaines | -32,20% |
Plus haut sur 52 semaines | 18,00 |
Plus bas sur 52 semaines | 10,29 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales